Enanta Pharmaceuticals, Inc. (ENTA)

USD 5.85

(-4.57%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 462.27 Million 375.41 Million 438.79 Million 486.13 Million 489.82 Million 414.22 Million
Total Current Assets 422.79 Million 311.71 Million 319.02 Million 436.83 Million 401.84 Million 380.38 Million
Cash And Short Term Investments 369.91 Million 249.23 Million 244 Million 386.64 Million 335.23 Million 308.73 Million
Cash and Cash Equivalents 85.38 Million 43.99 Million 57.2 Million 87.13 Million 51.23 Million 63.9 Million
Short Term Investments 284.52 Million 205.23 Million 186.79 Million 299.51 Million 284 Million 244.82 Million
Net Receivables 39.61 Million 49.03 Million 60.83 Million 23.49 Million 51.31 Million 67.2 Million
Inventory - - -37.25 Million - - -
Other Current Assets 13.26 Million 13.44 Million 51.44 Million 26.69 Million 15.29 Million 4.45 Million
Total Non-Current Assets 39.48 Million 63.69 Million 119.77 Million 49.29 Million 87.98 Million 33.83 Million
Net PPE 34.71 Million 29.74 Million 10.65 Million 15.61 Million 10.92 Million 8.37 Million
Good Will And Intangible Assets -11.53 Million -5.18 Million -2.06 Million - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 3.96 Million 29.28 Million 108.41 Million 32.63 Million 65.01 Million 16.38 Million
Tax Assets 7.56 Million 5.18 Million 2.06 Million 345 Thousand 11.34 Million 8.37 Million
Other Non Current Assets 4.77 Million 4.66 Million 700 Thousand 700 Thousand 700 Thousand 700 Thousand
Other Assets - - - - - -
Total Liabilities 245.54 Million 54.07 Million 39.36 Million 30.55 Million 27.33 Million 20.54 Million
Total Current Liabilities 62.78 Million 29.82 Million 36.17 Million 24.15 Million 22.6 Million 16.02 Million
Account Payables 4.09 Million 6 Million 9.54 Million 5.73 Million 6.68 Million 4.74 Million
Tax Payables - - - - - 1.38 Million
Short Term Debt 5.27 Million 2.89 Million 4.2 Million 4.26 Million - -
Deferred Revenue 18.33 Million - - - - -
Other Current Liabilities 35.07 Million 20.93 Million 22.42 Million 14.15 Million 15.92 Million 11.28 Million
Total Non Current Liabilities 182.75 Million 24.24 Million 3.19 Million 6.39 Million 4.72 Million 4.52 Million
Long-Term Debt 21.23 Million 22.37 Million 1.12 Million 3.83 Million 200 Thousand 293 Thousand
Deferred Revenue Non Current -7.56 Million -5.18 Million -2.06 Million 691 Thousand -318 Thousand -457 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 161.51 Million 1.87 Million 2.06 Million 1.07 Million 3.1 Million 2.89 Million
Other Liabilities - - - - - -
Total Equity 216.73 Million 321.33 Million 399.42 Million 455.58 Million 462.49 Million 393.67 Million
Stock Holders Equity 216.73 Million 321.33 Million 399.42 Million 455.58 Million 462.49 Million 393.67 Million
Common Stock 211 Thousand 208 Thousand 202 Thousand 201 Thousand 197 Thousand 194 Thousand
Retained Earnings -206.99 Million -73.17 Million 48.57 Million 127.57 Million 163.74 Million 117.35 Million
Accumulated other comprehensive income -1.17 Million -3.72 Million -382 Thousand 844 Thousand 146 Thousand -398 Thousand
Common Stock Equity 216.73 Million 321.33 Million 399.42 Million 455.58 Million 462.49 Million 393.67 Million
Capital Lease Obligation 26.51 Million 25.26 Million 5.32 Million 8.09 Million 200 Thousand 293 Thousand
Total Investments 284.52 Million 234.52 Million 295.21 Million 332.15 Million 349.01 Million 261.21 Million
Total Debt 26.51 Million 25.26 Million 5.32 Million 8.09 Million 200 Thousand 293 Thousand
Net Debt -58.87 Million -18.73 Million -51.87 Million -79.03 Million -51.03 Million -63.6 Million

Balance Sheet Charts